𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epoetin alfa improves hemoglobin levels and quality of life for lung cancer patients receiving chemotherapy

✍ Scribed by Crawford, J; Glaspy, J; Demetri, G; Gabrilove, J

Book ID
118570476
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
110 KB
Volume
29
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Relationship between changes in hemoglob
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy
✍ Jeffrey Crawford; David Cella; Charles S. Cleeland; Pierre-Yves Cremieux; George πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 1 views

## Background: Hemoglobin increases have been associated with quality of life (qol) improvements in anemic cancer patients treated with epoetin alfa, but intervention generally has been reserved for symptomatic anemia or hemoglobin < 10 g/dl. relationships among hemoglobin, functional status, and p

Epoetin alfa corrects anemia and improve
Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy
✍ Timothy J. Littlewood; Johan Nortier; Bernardo Rapoport; Marek Pawlicki; Gilbert πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 128 KB

Anemia, a commonly occurring morbidity in patients with cancer, often leads to diminished quality of life (QOL). Numerous clinical trials have shown that epoetin alfa treatment improves hematologic and QOL variables in cancer patients. The clinical trial analysis reported here was performed to asses

Epoetin alfa improves quality of life in
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy
✍ Paul J. Pockros; Mitchell L. Shiffman; Eugene R. Schiff; Mark S. Sulkowski; Zoba πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 221 KB

Anemia and decreased health-related quality of life (HRQL) are common in patients receiving combination therapy of interferon alfa (IFN) and ribavirin (RBV) for chronic hepatitis C virus (HCV) infection. In a randomized, prospective study evaluating the effectiveness of epoetin alfa in maintaining R